Treasure Valley Dialysis Center is a medicare approved dialysis facility center in Meridian, Idaho and it has 16 dialysis stations. It is located in Ada county at 3045 E St. Lukes Street Ste 105, Meridian, ID, 83642. You can reach out to the office of Treasure Valley Dialysis Center at (208) 887-2174. This dialysis clinic is managed and/or owned by Davita. Treasure Valley Dialysis Center has the following ownership type - Profit. It was first certified by medicare in August, 2006. The medicare id for this facility is 132513 and it accepts patients under medicare ESRD program.
| Name | Treasure Valley Dialysis Center |
|---|---|
| Location | 3045 E St. Lukes Street Ste 105, Meridian, Idaho |
| No. of Dialysis Stations | 16 |
| Medicare ID | 132513 |
| Managed By | Davita |
| Ownership Type | Profit |
| Late Shifts | Yes |
| 3045 E St. Lukes Street Ste 105, Meridian, Idaho, 83642 | |
| (208) 887-2174 | |
News Archive
During winter those who are active need to prepare for the cold conditions or risk injuries, warns Sports Medicine Australia.
John Kasich, the state's Republican governor, hints to The Cincinnati Enquirer that he might call for this step in his two-year budget plan, expected to be released in the next few days.
The researchers, Professor Michael Eysenck and Dr Nazanin Derkshan, designed several experiments to explore the effects of anxiety on our ability to perform tasks such as avoiding distractions on a computer screen, when reading a story, or solving a series of simple mathematics problems.
Children with attention deficit/hyperactivity disorder (ADHD) who take 36- or 54-mg doses of once-daily CONCERTA® (methylphenidate HCl) CII are more likely to achieve significantly greater symptom response and symptom reduction than children with ADHD who take CONCERTA 18 mg once daily or near-equivalent doses of methylphenidate three-times-a-day, a study shows.
Zafgen, Inc., a pharmaceutical company pioneering novel obesity therapeutics to help the body regain and sustain a lean, healthy state by targeting imbalances in fat metabolism, today announced new data from a Phase 1b study of ZGN-433, a selective methionine aminopeptidase 2 inhibitor (MetAP2), which showed a significant improvement in cardiovascular risk markers in severely obese subjects.
› Verified 6 days ago
| NPI Number | 1720032535 |
| Organization Name | Treasure Valley Dialysis Center |
| Doing Business As | Total Renal Care Inc |
| Address | 3045 E St Lukes St Meridian, Idaho, 83642 |
| Phone Number | (208) 887-2174 |
News Archive
During winter those who are active need to prepare for the cold conditions or risk injuries, warns Sports Medicine Australia.
John Kasich, the state's Republican governor, hints to The Cincinnati Enquirer that he might call for this step in his two-year budget plan, expected to be released in the next few days.
The researchers, Professor Michael Eysenck and Dr Nazanin Derkshan, designed several experiments to explore the effects of anxiety on our ability to perform tasks such as avoiding distractions on a computer screen, when reading a story, or solving a series of simple mathematics problems.
Children with attention deficit/hyperactivity disorder (ADHD) who take 36- or 54-mg doses of once-daily CONCERTA® (methylphenidate HCl) CII are more likely to achieve significantly greater symptom response and symptom reduction than children with ADHD who take CONCERTA 18 mg once daily or near-equivalent doses of methylphenidate three-times-a-day, a study shows.
Zafgen, Inc., a pharmaceutical company pioneering novel obesity therapeutics to help the body regain and sustain a lean, healthy state by targeting imbalances in fat metabolism, today announced new data from a Phase 1b study of ZGN-433, a selective methionine aminopeptidase 2 inhibitor (MetAP2), which showed a significant improvement in cardiovascular risk markers in severely obese subjects.
› Verified 6 days ago
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Patients who reported that nephrologists always communicated and cared for them. | 75% | 67% |
| Patients who reported that nephrologists usually communicated and cared for them. | 7% | 15% |
| Patients who reported that nephrologists sometimes or never communicated and cared for them. | 18% | 18% |
| Patients who gave their nephrologists a rating of 9 or 10 on a scale of 0 (worst possible) to 10 (best possible). | 71% | 60% |
| Patients who gave their nephrologists a rating of 7 or 8 on a scale of 0 (worst possible) to 10 (best possible). | 17% | 26% |
| Patients who gave their nephrologists a rating of 6 or less than 6 on a scale of 0 (worst possible) to 10 (best possible). | 12% | 14% |
News Archive
During winter those who are active need to prepare for the cold conditions or risk injuries, warns Sports Medicine Australia.
John Kasich, the state's Republican governor, hints to The Cincinnati Enquirer that he might call for this step in his two-year budget plan, expected to be released in the next few days.
The researchers, Professor Michael Eysenck and Dr Nazanin Derkshan, designed several experiments to explore the effects of anxiety on our ability to perform tasks such as avoiding distractions on a computer screen, when reading a story, or solving a series of simple mathematics problems.
Children with attention deficit/hyperactivity disorder (ADHD) who take 36- or 54-mg doses of once-daily CONCERTA® (methylphenidate HCl) CII are more likely to achieve significantly greater symptom response and symptom reduction than children with ADHD who take CONCERTA 18 mg once daily or near-equivalent doses of methylphenidate three-times-a-day, a study shows.
Zafgen, Inc., a pharmaceutical company pioneering novel obesity therapeutics to help the body regain and sustain a lean, healthy state by targeting imbalances in fat metabolism, today announced new data from a Phase 1b study of ZGN-433, a selective methionine aminopeptidase 2 inhibitor (MetAP2), which showed a significant improvement in cardiovascular risk markers in severely obese subjects.
› Verified 6 days ago
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Patients who reported that dialysis center staff always communicated well, kept patients comfortable and pain-free as possible. | 76% | 62% |
| Patients who reported that dialysis center staff usually communicated, kept patients comfortable and pain-free as possible. | 12% | 20% |
| Patients who reported that dialysis center staff sometimes or never communicated, kept patients comfortable and pain-free. | 12% | 18% |
| Patients who gave their dialysis facility staff a rating of 9 or 10 on a scale of 0 (worst possible) to 10 (best possible). | 72% | 62% |
| Patients who gave their dialysis facility staff a rating of 7 or 8 on a scale of 0 (worst possible) to 10 (best possible). | 22% | 26% |
| Patients who gave their dialysis facility staff a rating of 6 or less than 6 on a scale of 0 (worst possible) to 10 (best possible). | 6% | 12% |
News Archive
During winter those who are active need to prepare for the cold conditions or risk injuries, warns Sports Medicine Australia.
John Kasich, the state's Republican governor, hints to The Cincinnati Enquirer that he might call for this step in his two-year budget plan, expected to be released in the next few days.
The researchers, Professor Michael Eysenck and Dr Nazanin Derkshan, designed several experiments to explore the effects of anxiety on our ability to perform tasks such as avoiding distractions on a computer screen, when reading a story, or solving a series of simple mathematics problems.
Children with attention deficit/hyperactivity disorder (ADHD) who take 36- or 54-mg doses of once-daily CONCERTA® (methylphenidate HCl) CII are more likely to achieve significantly greater symptom response and symptom reduction than children with ADHD who take CONCERTA 18 mg once daily or near-equivalent doses of methylphenidate three-times-a-day, a study shows.
Zafgen, Inc., a pharmaceutical company pioneering novel obesity therapeutics to help the body regain and sustain a lean, healthy state by targeting imbalances in fat metabolism, today announced new data from a Phase 1b study of ZGN-433, a selective methionine aminopeptidase 2 inhibitor (MetAP2), which showed a significant improvement in cardiovascular risk markers in severely obese subjects.
› Verified 6 days ago
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Patients who reported that 'YES', their nephrologists and dialysis center staff provided them the information they needed to take care of them. | 81% | 80% |
| Patients who reported that 'NO', their nephrologists and dialysis center staff does not provided them the information they needed to take care of them. | 19% | 20% |
| Patients who gave their dialysis center a rating of 9 or 10 on a scale of 0 (worst possible) to 10 (best possible). | 92% | 68% |
| Patients who gave their dialysis center a rating of 7 or 8 on a scale of 0 (worst possible) to 10 (best possible). | 1% | 20% |
| Patients who gave their dialysis center a rating of 6 or less than 6 on a scale of 0 (worst possible) to 10 (best possible). | 7% | 12% |
News Archive
During winter those who are active need to prepare for the cold conditions or risk injuries, warns Sports Medicine Australia.
John Kasich, the state's Republican governor, hints to The Cincinnati Enquirer that he might call for this step in his two-year budget plan, expected to be released in the next few days.
The researchers, Professor Michael Eysenck and Dr Nazanin Derkshan, designed several experiments to explore the effects of anxiety on our ability to perform tasks such as avoiding distractions on a computer screen, when reading a story, or solving a series of simple mathematics problems.
Children with attention deficit/hyperactivity disorder (ADHD) who take 36- or 54-mg doses of once-daily CONCERTA® (methylphenidate HCl) CII are more likely to achieve significantly greater symptom response and symptom reduction than children with ADHD who take CONCERTA 18 mg once daily or near-equivalent doses of methylphenidate three-times-a-day, a study shows.
Zafgen, Inc., a pharmaceutical company pioneering novel obesity therapeutics to help the body regain and sustain a lean, healthy state by targeting imbalances in fat metabolism, today announced new data from a Phase 1b study of ZGN-433, a selective methionine aminopeptidase 2 inhibitor (MetAP2), which showed a significant improvement in cardiovascular risk markers in severely obese subjects.
› Verified 6 days ago
| Dialysis patients with Hemoglobin data | 32 |
| Medicare patients who had average hemoglobin (hgb) less than 10 g/dL | 19 |
News Archive
During winter those who are active need to prepare for the cold conditions or risk injuries, warns Sports Medicine Australia.
John Kasich, the state's Republican governor, hints to The Cincinnati Enquirer that he might call for this step in his two-year budget plan, expected to be released in the next few days.
The researchers, Professor Michael Eysenck and Dr Nazanin Derkshan, designed several experiments to explore the effects of anxiety on our ability to perform tasks such as avoiding distractions on a computer screen, when reading a story, or solving a series of simple mathematics problems.
Children with attention deficit/hyperactivity disorder (ADHD) who take 36- or 54-mg doses of once-daily CONCERTA® (methylphenidate HCl) CII are more likely to achieve significantly greater symptom response and symptom reduction than children with ADHD who take CONCERTA 18 mg once daily or near-equivalent doses of methylphenidate three-times-a-day, a study shows.
Zafgen, Inc., a pharmaceutical company pioneering novel obesity therapeutics to help the body regain and sustain a lean, healthy state by targeting imbalances in fat metabolism, today announced new data from a Phase 1b study of ZGN-433, a selective methionine aminopeptidase 2 inhibitor (MetAP2), which showed a significant improvement in cardiovascular risk markers in severely obese subjects.
› Verified 6 days ago
Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.
| Adult patients getting regular hemodialysis at the center | 60 |
| Adult patient months included in Kt/V greater than or equal to 1.2 | 574 |
| Percentage of adult patients getting regular hemodialysis at the center | 97 |
| Percentage of pediatric patients getting regular hemodialysis at the center |
News Archive
During winter those who are active need to prepare for the cold conditions or risk injuries, warns Sports Medicine Australia.
John Kasich, the state's Republican governor, hints to The Cincinnati Enquirer that he might call for this step in his two-year budget plan, expected to be released in the next few days.
The researchers, Professor Michael Eysenck and Dr Nazanin Derkshan, designed several experiments to explore the effects of anxiety on our ability to perform tasks such as avoiding distractions on a computer screen, when reading a story, or solving a series of simple mathematics problems.
Children with attention deficit/hyperactivity disorder (ADHD) who take 36- or 54-mg doses of once-daily CONCERTA® (methylphenidate HCl) CII are more likely to achieve significantly greater symptom response and symptom reduction than children with ADHD who take CONCERTA 18 mg once daily or near-equivalent doses of methylphenidate three-times-a-day, a study shows.
Zafgen, Inc., a pharmaceutical company pioneering novel obesity therapeutics to help the body regain and sustain a lean, healthy state by targeting imbalances in fat metabolism, today announced new data from a Phase 1b study of ZGN-433, a selective methionine aminopeptidase 2 inhibitor (MetAP2), which showed a significant improvement in cardiovascular risk markers in severely obese subjects.
› Verified 6 days ago
| Adult patients getting regular peritoneal dialysis at the center | 16 |
| Adult patient months included in Kt/V greater than or equal to 1.7 | 131 |
| Percentage of adult patients getting regular peritoneal dialysis at the center | 98 |
| Percentage of pediatric patients getting regular peritoneal dialysis at the center |
News Archive
During winter those who are active need to prepare for the cold conditions or risk injuries, warns Sports Medicine Australia.
John Kasich, the state's Republican governor, hints to The Cincinnati Enquirer that he might call for this step in his two-year budget plan, expected to be released in the next few days.
The researchers, Professor Michael Eysenck and Dr Nazanin Derkshan, designed several experiments to explore the effects of anxiety on our ability to perform tasks such as avoiding distractions on a computer screen, when reading a story, or solving a series of simple mathematics problems.
Children with attention deficit/hyperactivity disorder (ADHD) who take 36- or 54-mg doses of once-daily CONCERTA® (methylphenidate HCl) CII are more likely to achieve significantly greater symptom response and symptom reduction than children with ADHD who take CONCERTA 18 mg once daily or near-equivalent doses of methylphenidate three-times-a-day, a study shows.
Zafgen, Inc., a pharmaceutical company pioneering novel obesity therapeutics to help the body regain and sustain a lean, healthy state by targeting imbalances in fat metabolism, today announced new data from a Phase 1b study of ZGN-433, a selective methionine aminopeptidase 2 inhibitor (MetAP2), which showed a significant improvement in cardiovascular risk markers in severely obese subjects.
› Verified 6 days ago
An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at Treasure Valley Dialysis Center with elevated calcium levels.
| Patients with hypercalcemia | 76 |
| Hypercalcemia patient months | 713 |
| Hypercalcemia patients with serumcalcium greater than 10.2 mg | 1 |
| Patients with Serumphosphor | 80 |
| Patients with Serumphosphor less than 3.5 mg/dL | 7 |
| Patients with Serumphosphor from 3.5 to 4.5 mg/dL | 20 |
| Patients with Serumphosphor from 4.6 to 5.5 mg/dL | 32 |
| Patients with Serumphosphor from 5.6 to 7 mg/dL | 22 |
| Patients with Serumphosphor greater than 7 mg/dL | 20 |
News Archive
During winter those who are active need to prepare for the cold conditions or risk injuries, warns Sports Medicine Australia.
John Kasich, the state's Republican governor, hints to The Cincinnati Enquirer that he might call for this step in his two-year budget plan, expected to be released in the next few days.
The researchers, Professor Michael Eysenck and Dr Nazanin Derkshan, designed several experiments to explore the effects of anxiety on our ability to perform tasks such as avoiding distractions on a computer screen, when reading a story, or solving a series of simple mathematics problems.
Children with attention deficit/hyperactivity disorder (ADHD) who take 36- or 54-mg doses of once-daily CONCERTA® (methylphenidate HCl) CII are more likely to achieve significantly greater symptom response and symptom reduction than children with ADHD who take CONCERTA 18 mg once daily or near-equivalent doses of methylphenidate three-times-a-day, a study shows.
Zafgen, Inc., a pharmaceutical company pioneering novel obesity therapeutics to help the body regain and sustain a lean, healthy state by targeting imbalances in fat metabolism, today announced new data from a Phase 1b study of ZGN-433, a selective methionine aminopeptidase 2 inhibitor (MetAP2), which showed a significant improvement in cardiovascular risk markers in severely obese subjects.
› Verified 6 days ago
The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.
| Patients included in arterial venous fistula and catheter summaries | 58 |
| Patient months included in arterial venous fistula and catheter summaries | 389 |
| Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment | 81 |
| Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer | 12 |
News Archive
During winter those who are active need to prepare for the cold conditions or risk injuries, warns Sports Medicine Australia.
John Kasich, the state's Republican governor, hints to The Cincinnati Enquirer that he might call for this step in his two-year budget plan, expected to be released in the next few days.
The researchers, Professor Michael Eysenck and Dr Nazanin Derkshan, designed several experiments to explore the effects of anxiety on our ability to perform tasks such as avoiding distractions on a computer screen, when reading a story, or solving a series of simple mathematics problems.
Children with attention deficit/hyperactivity disorder (ADHD) who take 36- or 54-mg doses of once-daily CONCERTA® (methylphenidate HCl) CII are more likely to achieve significantly greater symptom response and symptom reduction than children with ADHD who take CONCERTA 18 mg once daily or near-equivalent doses of methylphenidate three-times-a-day, a study shows.
Zafgen, Inc., a pharmaceutical company pioneering novel obesity therapeutics to help the body regain and sustain a lean, healthy state by targeting imbalances in fat metabolism, today announced new data from a Phase 1b study of ZGN-433, a selective methionine aminopeptidase 2 inhibitor (MetAP2), which showed a significant improvement in cardiovascular risk markers in severely obese subjects.
› Verified 6 days ago
The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.
| Standard Hospitalization Summary Ratio(SHR) Year | January, 2016 - December, 2016 |
| Patients in facility's Hospitalization Summary | 62 |
| Hospitalization Rate in facility | 157 (As Expected) |
| Hospitalization Rate: Upper Confidence Limit | 291.4 |
| Hospitalization Rate: Lower Confidence Limit | 88.3 |
News Archive
During winter those who are active need to prepare for the cold conditions or risk injuries, warns Sports Medicine Australia.
John Kasich, the state's Republican governor, hints to The Cincinnati Enquirer that he might call for this step in his two-year budget plan, expected to be released in the next few days.
The researchers, Professor Michael Eysenck and Dr Nazanin Derkshan, designed several experiments to explore the effects of anxiety on our ability to perform tasks such as avoiding distractions on a computer screen, when reading a story, or solving a series of simple mathematics problems.
Children with attention deficit/hyperactivity disorder (ADHD) who take 36- or 54-mg doses of once-daily CONCERTA® (methylphenidate HCl) CII are more likely to achieve significantly greater symptom response and symptom reduction than children with ADHD who take CONCERTA 18 mg once daily or near-equivalent doses of methylphenidate three-times-a-day, a study shows.
Zafgen, Inc., a pharmaceutical company pioneering novel obesity therapeutics to help the body regain and sustain a lean, healthy state by targeting imbalances in fat metabolism, today announced new data from a Phase 1b study of ZGN-433, a selective methionine aminopeptidase 2 inhibitor (MetAP2), which showed a significant improvement in cardiovascular risk markers in severely obese subjects.
› Verified 6 days ago
The rate of readmission show you whether patients who were being treated regularly at Treasure Valley Dialysis Center were readmitted more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other dialysis centers.
| Standard Readmission Summary Ratio(SRR) Year | January, 2016 - December, 2016 |
| Readmission Rate in facility | 22 (As Expected) |
| Readmission Rate: Upper Confidence Limit | 36.6 |
| Readmission Rate: Lower Confidence Limit | 11.2 |
News Archive
During winter those who are active need to prepare for the cold conditions or risk injuries, warns Sports Medicine Australia.
John Kasich, the state's Republican governor, hints to The Cincinnati Enquirer that he might call for this step in his two-year budget plan, expected to be released in the next few days.
The researchers, Professor Michael Eysenck and Dr Nazanin Derkshan, designed several experiments to explore the effects of anxiety on our ability to perform tasks such as avoiding distractions on a computer screen, when reading a story, or solving a series of simple mathematics problems.
Children with attention deficit/hyperactivity disorder (ADHD) who take 36- or 54-mg doses of once-daily CONCERTA® (methylphenidate HCl) CII are more likely to achieve significantly greater symptom response and symptom reduction than children with ADHD who take CONCERTA 18 mg once daily or near-equivalent doses of methylphenidate three-times-a-day, a study shows.
Zafgen, Inc., a pharmaceutical company pioneering novel obesity therapeutics to help the body regain and sustain a lean, healthy state by targeting imbalances in fat metabolism, today announced new data from a Phase 1b study of ZGN-433, a selective methionine aminopeptidase 2 inhibitor (MetAP2), which showed a significant improvement in cardiovascular risk markers in severely obese subjects.
› Verified 6 days ago
Hemodialysis treatment requires direct access to the bloodstream, which can be an opportunity for germs to enter the body and cause infection. This information shows how often patients at Treasure Valley Dialysis Center get infections in their blood each year compared to the number of infections expected for the center based on the national average.
| Standard Infection Summary Ratio(SIR) Year | January, 2016 - December, 2016 |
| Infection Rate in facility | .72 (As Expected) |
| SIR: Upper Confidence Limit | 1.95 |
| SIR: Lower Confidence Limit | .18 |
News Archive
During winter those who are active need to prepare for the cold conditions or risk injuries, warns Sports Medicine Australia.
John Kasich, the state's Republican governor, hints to The Cincinnati Enquirer that he might call for this step in his two-year budget plan, expected to be released in the next few days.
The researchers, Professor Michael Eysenck and Dr Nazanin Derkshan, designed several experiments to explore the effects of anxiety on our ability to perform tasks such as avoiding distractions on a computer screen, when reading a story, or solving a series of simple mathematics problems.
Children with attention deficit/hyperactivity disorder (ADHD) who take 36- or 54-mg doses of once-daily CONCERTA® (methylphenidate HCl) CII are more likely to achieve significantly greater symptom response and symptom reduction than children with ADHD who take CONCERTA 18 mg once daily or near-equivalent doses of methylphenidate three-times-a-day, a study shows.
Zafgen, Inc., a pharmaceutical company pioneering novel obesity therapeutics to help the body regain and sustain a lean, healthy state by targeting imbalances in fat metabolism, today announced new data from a Phase 1b study of ZGN-433, a selective methionine aminopeptidase 2 inhibitor (MetAP2), which showed a significant improvement in cardiovascular risk markers in severely obese subjects.
› Verified 6 days ago
Patients with anemia require blood transfusions if their anemia is not managed well by their dialysis center. This information shows whether Treasure Valley Dialysis Center's rate of transfusions is better than expected, as expected, or worse than expected, compared to other centers that treat similar patients.
| Standard Transfusion Summary Ratio (STrR) Year | January, 2016 - December, 2016 |
| Patients in facility's Transfusion Summary | 52 |
| Transfusion Rate in facility | 17.2 (As Expected) |
| Transfusion Rate: Upper Confidence Limit | 83.6 |
| Transfusion Rate: Lower Confidence Limit | 4.3 |
News Archive
During winter those who are active need to prepare for the cold conditions or risk injuries, warns Sports Medicine Australia.
John Kasich, the state's Republican governor, hints to The Cincinnati Enquirer that he might call for this step in his two-year budget plan, expected to be released in the next few days.
The researchers, Professor Michael Eysenck and Dr Nazanin Derkshan, designed several experiments to explore the effects of anxiety on our ability to perform tasks such as avoiding distractions on a computer screen, when reading a story, or solving a series of simple mathematics problems.
Children with attention deficit/hyperactivity disorder (ADHD) who take 36- or 54-mg doses of once-daily CONCERTA® (methylphenidate HCl) CII are more likely to achieve significantly greater symptom response and symptom reduction than children with ADHD who take CONCERTA 18 mg once daily or near-equivalent doses of methylphenidate three-times-a-day, a study shows.
Zafgen, Inc., a pharmaceutical company pioneering novel obesity therapeutics to help the body regain and sustain a lean, healthy state by targeting imbalances in fat metabolism, today announced new data from a Phase 1b study of ZGN-433, a selective methionine aminopeptidase 2 inhibitor (MetAP2), which showed a significant improvement in cardiovascular risk markers in severely obese subjects.
› Verified 6 days ago
The rate of mortality show you whether patients who were being treated regularly at Treasure Valley Dialysis Center lived longer than expected (better than expected), don’t live as long as expected (worse than expected), or lived as long as expected (as expected), compared to similar patients treated at other facilities.
| Standard Survival Summary Ratio(SIR) Year | January, 2013 - December, 2016 |
| Patients in facility's Survival Summary | 272 |
| Mortality Rate in facility | 17.2 (As Expected) |
| Mortality Rate: Upper Confidence Limit | 24.4 |
| Mortality Rate: Lower Confidence Limit | 11.7 |
News Archive
During winter those who are active need to prepare for the cold conditions or risk injuries, warns Sports Medicine Australia.
John Kasich, the state's Republican governor, hints to The Cincinnati Enquirer that he might call for this step in his two-year budget plan, expected to be released in the next few days.
The researchers, Professor Michael Eysenck and Dr Nazanin Derkshan, designed several experiments to explore the effects of anxiety on our ability to perform tasks such as avoiding distractions on a computer screen, when reading a story, or solving a series of simple mathematics problems.
Children with attention deficit/hyperactivity disorder (ADHD) who take 36- or 54-mg doses of once-daily CONCERTA® (methylphenidate HCl) CII are more likely to achieve significantly greater symptom response and symptom reduction than children with ADHD who take CONCERTA 18 mg once daily or near-equivalent doses of methylphenidate three-times-a-day, a study shows.
Zafgen, Inc., a pharmaceutical company pioneering novel obesity therapeutics to help the body regain and sustain a lean, healthy state by targeting imbalances in fat metabolism, today announced new data from a Phase 1b study of ZGN-433, a selective methionine aminopeptidase 2 inhibitor (MetAP2), which showed a significant improvement in cardiovascular risk markers in severely obese subjects.
› Verified 6 days ago
Liberty Dialysis - Meridian Location: 3525 E Louise Dr Suite 100, Meridian, Idaho, 83642 Phone: (208) 846-9815 |
Treasure Valley Dialysis Center Location: 3045 E St. Lukes Street Ste 105, Meridian, Idaho, 83642 Phone: (208) 887-2174 |
News Archive
During winter those who are active need to prepare for the cold conditions or risk injuries, warns Sports Medicine Australia.
John Kasich, the state's Republican governor, hints to The Cincinnati Enquirer that he might call for this step in his two-year budget plan, expected to be released in the next few days.
The researchers, Professor Michael Eysenck and Dr Nazanin Derkshan, designed several experiments to explore the effects of anxiety on our ability to perform tasks such as avoiding distractions on a computer screen, when reading a story, or solving a series of simple mathematics problems.
Children with attention deficit/hyperactivity disorder (ADHD) who take 36- or 54-mg doses of once-daily CONCERTA® (methylphenidate HCl) CII are more likely to achieve significantly greater symptom response and symptom reduction than children with ADHD who take CONCERTA 18 mg once daily or near-equivalent doses of methylphenidate three-times-a-day, a study shows.
Zafgen, Inc., a pharmaceutical company pioneering novel obesity therapeutics to help the body regain and sustain a lean, healthy state by targeting imbalances in fat metabolism, today announced new data from a Phase 1b study of ZGN-433, a selective methionine aminopeptidase 2 inhibitor (MetAP2), which showed a significant improvement in cardiovascular risk markers in severely obese subjects.
› Verified 6 days ago